Status:
COMPLETED
Study of Inactivated Poliovirus Vaccine Given at an Earlier Schedule With Shorter Intervals
Lead Sponsor:
Pan American Health Organization
Collaborating Sponsors:
World Health Organization
Institute Pedro Kouri, Ministry of Public Health (Cuba)
Conditions:
Level of Immunity Against Poliovirus Infection
Eligibility:
MALE
6-2 years
Phase:
NA
Brief Summary
The purpose of this study was to evaluated the effectiveness of inactivated poliovirus vaccine at a vaccine schedule that is commonly used in developing countries. The effectiveness of inactivated pol...
Detailed Description
After polio eradication, access to live polioviruses will be highly restricted, and oral poliovirus vaccine (OPV) use must be discontinued. OPV-using countries must decide whether to switch to inactiv...
Eligibility Criteria
Inclusion
- Infants born 18 - 20 weeks prior to the first round of the 2002 National Immunization Days in cuba (in March 2002).
- Born healthy at one of the 4 designated maternity hospitals in Cuba
Exclusion
- Serious congenital defect/disease at birth
- \-
Key Trial Info
Start Date :
August 1 2001
Trial Type :
INTERVENTIONAL
End Date :
January 1 2003
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00260312
Start Date
August 1 2001
End Date
January 1 2003
Last Update
December 1 2005
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.